Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals Of The Week: UCB/Wilex, J&J/Vanderbilt, Alnylam/Cubist ...

Executive Summary

Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.

You may also be interested in...



Expanding The Knowledge Tree: Big Pharma & Academia Pairings On The Rise

As Big Pharma companies seek partnerships with academia to drive innovation and replenish drying pipelines, more are warming to the idea that the rewards need to be shared to keep collaborations intact long enough to see results

Expanding The Knowledge Tree: Big Pharma & Academia Pairings On The Rise

As Big Pharma companies seek partnerships with academia to drive innovation and replenish drying pipelines, more are warming to the idea that the rewards need to be shared to keep collaborations intact long enough to see results

GSK Partners Leftover Assets With Academia

GlaxoSmithKline's Academic Drug Performance Unit isn't focused on what one might expect -trawling academic institutions for promising science and compounds to eventually bring into the fold

Related Content

Topics

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel